Covid-19: ROVER-An Open-Label, Phase 3 Study to Evaluate the Safety and Immunogenicity of the mRNA-1273.214 Vaccine for SARS-CoV-2 Variants of Concern in Participants Aged 6 Months to < 6 Years

Grants and Contracts Details

StatusActive
Effective start/end date8/8/226/6/23

Funding

  • PPD Investigator Services LLC: $9,433.00